These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 30804940)

  • 1. Immune Responses to the Sexual Stages of
    Kengne-Ouafo JA; Sutherland CJ; Binka FN; Awandare GA; Urban BC; Dinko B
    Front Immunol; 2019; 10():136. PubMed ID: 30804940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.
    de Jong RM; Tebeje SK; Meerstein-Kessel L; Tadesse FG; Jore MM; Stone W; Bousema T
    Immunol Rev; 2020 Jan; 293(1):190-215. PubMed ID: 31840844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally acquired immunity to sexual stage P. falciparum parasites.
    Stone WJ; Dantzler KW; Nilsson SK; Drakeley CJ; Marti M; Bousema T; Rijpma SR
    Parasitology; 2016 Feb; 143(2):187-98. PubMed ID: 26743529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon.
    Gebru T; Ajua A; Theisen M; Esen M; Ngoa UA; Issifou S; Adegnika AA; Kremsner PG; Mordmüller B; Held J
    Malar J; 2017 Apr; 16(1):176. PubMed ID: 28446190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIMMS43 is required for malaria parasite immune evasion and sporogonic development in the mosquito vector.
    Ukegbu CV; Giorgalli M; Tapanelli S; Rona LDP; Jaye A; Wyer C; Angrisano F; Blagborough AM; Christophides GK; Vlachou D
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7363-7373. PubMed ID: 32165544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasmodium vivax and Plasmodium falciparum gametocyte stages are neglected in vaccine development].
    Contreras-Ochoa C; Ramsey JM
    Salud Publica Mex; 2004; 46(1):64-70. PubMed ID: 15053398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural vaccinology of malaria transmission-blocking vaccines.
    Patel PN; Tolia N
    Expert Rev Vaccines; 2021 Feb; 20(2):199-214. PubMed ID: 33430656
    [No Abstract]   [Full Text] [Related]  

  • 8. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?
    Sutherland CJ
    Mol Biochem Parasitol; 2009 Aug; 166(2):93-8. PubMed ID: 19450726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum Calcium-Dependent Protein Kinase 4 is Critical for Male Gametogenesis and Transmission to the Mosquito Vector.
    Kumar S; Haile MT; Hoopmann MR; Tran LT; Michaels SA; Morrone SR; Ojo KK; Reynolds LM; Kusebauch U; Vaughan AM; Moritz RL; Kappe SHI; Swearingen KE
    mBio; 2021 Dec; 12(6):e0257521. PubMed ID: 34724830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.
    Gowda DC; Wu X
    Front Immunol; 2018; 9():3006. PubMed ID: 30619355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.
    Paul NH; Vengesai A; Mduluza T; Chipeta J; Midzi N; Bansal GP; Kumar N
    Acta Trop; 2016 Nov; 163():103-8. PubMed ID: 27491342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mosquito Vectors and the Globalization of Plasmodium falciparum Malaria.
    Molina-Cruz A; Zilversmit MM; Neafsey DE; Hartl DL; Barillas-Mury C
    Annu Rev Genet; 2016 Nov; 50():447-465. PubMed ID: 27732796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission-Blocking Vaccines: Old Friends and New Prospects.
    Acquah FK; Adjah J; Williamson KC; Amoah LE
    Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30962400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune mechanisms targeting malaria transmission: opportunities for vaccine development.
    Bansal GP; Kumar N
    Expert Rev Vaccines; 2024; 23(1):645-654. PubMed ID: 38888098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies & recent development of transmission-blocking vaccines against
    Chaturvedi N; Bharti PK; Tiwari A; Singh N
    Indian J Med Res; 2016 Jun; 143(6):696-711. PubMed ID: 27748294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
    Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
    Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Helminth Infections, Plasmodium falciparum Parasite Carriage and Antibody Responses to Sexual and Asexual Stage Malarial Antigens.
    Ateba-Ngoa U; Jones S; Zinsou JF; Honkpehedji J; Adegnika AA; Agobe JC; Massinga-Loembe M; Mordmüller B; Bousema T; Yazdanbakhsh M
    Am J Trop Med Hyg; 2016 Aug; 95(2):394-400. PubMed ID: 27273645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.